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conservative, True Selective
nvasive, and Routine
nvasive Strategies in
on–ST-Segment Elevation
cute Coronary Syndromes
e read with interest the meta-analysis published by Fox et al. (1)
f long-term outcome of a routine versus selective invasive strategy
n patients with non–ST-segment elevation acute coronary syn-
romes (1). By pooling individual data from the FRISC (Fast
evascularization During Instability in Coronary Artery Disease)
I trial, the RITA (Randomized Intervention Trial of Unstable
ngina) 3 study, and the ICTUS (Invasive Versus Conservative
reatment in Unstable Coronary Syndromes) trial, they analyzed
he effects of the management policy in terms of hard events with
reater statistical power. The main conclusion was that routine
nvasive strategy was superior in reducing long-term rates of
ardiovascular death or myocardial infarction. This means an
mportant step in the management of non–ST-segment elevation
cute coronary syndromes that will further promote the use of
nvasive approach and, consequently, transferring patients to hos-
itals with catheterization laboratory facilities (2,3).
Our concern, however, rests on the heterogeneity inherent to
he definition of a selective invasive strategy. The differences found
n the trials when comparing the 2 strategies could be closely
inked to the way the conservative group was treated: the greater
he restriction for cardiac catheterization in the conservative arm,
he greater the benefit for the invasive arm. For instance, the
onservative approach in the FRISC II trial (angiography if
pontaneous recurrent angina or severe ischemia on the exercise
est defined by ST-segment depression 0.3 mV, ST-segment
levation or limited chest pain associated with a low maximum
ork load or a decrease in blood pressure) and the RITA 3 study
angiography driven exclusively by symptoms), differed substan-
ially from the true selective invasive approach in the ICTUS trial
angiography if spontaneous recurrent angina or clinically signifi-
ant ischemia on the exercise test) (4–6). As result, the revascu-
arization rates at the index hospitalization in the conservative
roups were 9% in the FRISC II study, 10% in the RITA 3 study,
nd as high as 40% in the ICTUS trial. These differences may
xplain why the results were favorable to the invasive strategy in
he FRISC II and RITA 3 studies, whereas they were neutral in
he ICTUS study. Consequently, pooling the 3 studies implies the
ssumption that all the strategies in the conservative groups were
quivalent, which does not seem to be the case. We believe that an
ndividual patient data meta-analysis may have the capacity to
ccount for some degree of heterogeneity in trials design, but not
hen the exposure variable differed substantially in its definition.
herefore, because of this limitation, the superiority of an invasiveersus a true selective invasive strategy is still unresolved. DOur personal view is that patients with non–ST-segment
levation acute coronary syndromes should be invasively managed
7), and that a true selective invasive strategy, as proposed in the
CTUS trial, constitutes a valuable alternative.
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The first point raised was that there was heterogeneity in the
efinition of the selective invasive strategy, in the 3 studies
omprising the meta-analysis. In our paper, we discuss factors that
ay account for the trial-to-trial differences (page 2,441), and
hese not only include the differences in the rate of revasculariza-
ion in the “selective invasive arm” but also differences in inclusion
riteria. As we point out, the FRISC (Fast Revascularization
uring Instability in Coronary Artery Disease) II trial and the
